Publications by authors named "Susu He"

Article Synopsis
  • Interleukin-18 (IL-18) enhances immune responses, but its clinical use is limited by a decoy receptor; to overcome this, researchers developed a variant called DR18 that doesn't bind to IL-18 binding protein.
  • They tested this DR18 variant using an oncolytic adenovirus (oAdDR18) in mouse models of different tumors to see its effects on tumor growth and immune response.
  • Results showed that oAdDR18 led to significant tumor growth reduction and enhanced immune cell infiltration compared to other forms of IL-18, indicating strong potential for treating cancers and reducing metastasis.
View Article and Find Full Text PDF
Article Synopsis
  • Pseudomonas aeruginosa causes respiratory infections in cystic fibrosis patients and produces a virulence factor called Cif, which worsens patient outcomes by decreasing CFTR levels and disrupting healing signals.!* -
  • The virulence factor Cif is regulated by a protein called CifR, which is the first known bacterial transcriptional regulator that senses epoxides, although how it functions at a molecular level has not been fully explored.!* -
  • Through biochemical and structural studies, researchers revealed how CifR binds to DNA and identified key changes in its structure that facilitate gene regulation, highlighting the critical role of the Cys107 residue in sensing epoxides and releasing DNA.!*
View Article and Find Full Text PDF

Objective: To investigate the relationship between post-traumatic growth, morbidity stigma and readiness for discharge in post-operative thyroid cancer patients.

Methods: 422 post-operative thyroid cancer patients from three tertiary care hospitals in Hunan and Tianjin were surveyed using the General Information Questionnaire, the Post-traumatic Growth Scale, the Readiness for Discharge Scale, and the Social Influence Scale.

Results: Discharge readiness positively predicted the level of post-traumatic growth in thyroid cancer patients (P < 0.

View Article and Find Full Text PDF
Article Synopsis
  • Lymphotoxin α (LTα) is a substance produced by active lymphocytes that can kill tumor cells, but its clinical use has been limited due to instability and systemic toxicity.
  • Researchers developed a mutant form of LTα (LTα Q107E) that specifically targets the TNFR1 receptor and demonstrated its effectiveness in promoting antitumor activity.
  • An experimental oncolytic adenovirus carrying this LTα mutant (oAdQ2) was tested in mouse models and showed reduced tumor growth and increased infiltration of immune cells, suggesting improved therapeutic potential for cancer treatment.
View Article and Find Full Text PDF

The opportunistic pathogen infects cystic fibrosis (CF) patient airways and produces a virulence factor Cif that is associated with worse outcomes. Cif is an epoxide hydrolase that reduces cell-surface abundance of the cystic fibrosis transmembrane conductance regulator (CFTR) and sabotages pro-resolving signals. Its expression is regulated by a divergently transcribed TetR family transcriptional repressor.

View Article and Find Full Text PDF

Background: Third-generation epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKI) show good selectivity for classical EGFR mutated and EGFR T790M mutated non-small cell lung cancer (NSCLC). However, resistance inevitably occurs to third-generation EGFR-TKI. This study describes the real-world characteristics, efficacy, and safety of treating post-progression NSCLC with 160 mg of furmonertinib (in combination with or without anti-angiogenic agents and chemotherapy) with third-generation EGFR-TKIs.

View Article and Find Full Text PDF

Immune-related adverse reactions primarily involve the skin and the endocrine, digestive, and respiratory systems. In the endocrine system, these adverse effects mainly include hypophysitis, thyroiditis, hypoadrenalism, and rarely, diabetes mellitus. The most common symptoms in the skin are pruritus, rash, and infrequently, eruptive keratoacanthoma.

View Article and Find Full Text PDF
Article Synopsis
  • Long Interspersed Element 1 (L1) plays a crucial role in regulating the genome and evolution, and its expression is influenced by viral infections, affecting the host's immune response and disease progression.
  • In the context of Epstein-Barr virus (EBV) and gastric cancer, research shows that EBV-associated gastric cancer (EBVaGC) exhibits decreased L1 transcription compared to EBV-negative gastric cancer (EBVnGC), particularly affecting young and full-length L1s (FL-L1s).
  • The study suggests that increased H3K9me3 levels, linked to heightened TASOR expression, contribute to the repression of FL-L1s, demonstrating how EBV infection can reshape chromatin structure and
View Article and Find Full Text PDF
Article Synopsis
  • - Respiratory syncytial virus (RSV) is a major cause of lung infections in infants and the elderly, but there are currently no specific treatments for it.
  • - Researchers tested Axl inhibitors, which block a receptor involved in regulating the immune response, and found that they significantly reduced RSV infection in both cell cultures and animal models.
  • - The study suggests that Axl inhibitors can enhance the body’s antiviral response, leading to increased immune activity and a reduction in virus levels and inflammation in the lungs.
View Article and Find Full Text PDF

Rearrangements of the anaplastic lymphoma kinase (ALK) gene account for 5-6% in non-small cell lung cancer (NSCLC). ALK rearranged NSCLC is sensitive to ALK tyrosine kinase inhibitors (TKIs) but prone to drug resistance. Meanwhile, ALK rearranged NSCLC has poor response to single immunotherapy.

View Article and Find Full Text PDF
Article Synopsis
  • Respiratory syncytial virus (RSV) is a major cause of serious lung infections in infants and young kids, and Axl, a receptor protein, plays a role in this process.
  • Research shows that Axl actually helps the virus by suppressing the body's antiviral defenses, as evidence from studies with human cells and Axl-deficient mice indicates increased resistance to RSV.
  • The findings suggest that the Axl protein not only acts as a receptor for the virus but also inhibits important immune signaling pathways, which could impact how the body fights off RSV infections.
View Article and Find Full Text PDF

Methods: The clinical data of six patients with primary pulmonary lymphoepithelioma-like carcinoma treated in Zhejiang Taizhou Hospital of Taizhou Enze Medical Center (Group) from May 2014 to December 2018 were summarized and analyzed. Combined with the relevant literature, the primary pulmonary lymphoepithelioma-like carcinoma was analyzed retrospectively.

Results: The main manifestations of six patients were respiratory symptoms, and cough was the most common.

View Article and Find Full Text PDF

Purpose: To investigate the recovery of lung function and chest imaging in patients with COVID-19 three months after clinical cure and discharge and the correlation between them.

Methods: This study collected 80 patients diagnosed with 2019-nCoV infection who were discharged from the Taizhou Public Health Medical Center in Zhejiang Province between January 31, 2020, and March 10, 2020. Lung function examinations and lung CT scans were performed at discharge and three months after discharge.

View Article and Find Full Text PDF

Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infections in infants and young children. Severe respiratory viral infection in early life is intimately associated with childhood recurrent wheezing and is a risk factor for asthma later in life. Although eosinophilic airway inflammation is an important trait in asthma of children, the roles of pulmonary eosinophils in the disease have been inadequately understood.

View Article and Find Full Text PDF

Background: Novel coronavirus disease 2019 (COVID-19) was discovered in December 2019 and has infected more than 80 million people worldwide, and more than 50 million people have achieved a clinical cure. In this study, the pulmonary function results of patients after clinical medicine for three months were reported.

Objective: To investigate the effect of COVID-19 on lung function in patients.

View Article and Find Full Text PDF

PD-L1 is one of the current biomarkers for immune checkpoint inhibitor (ICI) therapy in patients with non-small-cell lung cancer. However, the expression of PD-L1 in the real world and its related influencing factors remain unclear. We want to observe the expression of PD-L1 in the real world and study the related influencing factors through the collection and analysis of clinical data.

View Article and Find Full Text PDF

The IS6 family of insertion sequences is a large but coherent group which was originally named to avoid confusion between a number of identical or nearly identical IS that were identified at about the same time and given different names (IS15D, IS26, IS46, IS140, IS160, IS176). The underlying common mechanistic feature of all IS6 family members which have been investigated is that they appear to transpose by replicative transposition and form pseudo compound transposons with the flanking IS in direct repeat and in which associated genes are simply transferred to the target replicon and lost from the donor.In the accompanying letter Hall raises a number of very serious and wide-ranging criticisms of our recent review article concerning the IS6 family of insertion sequences.

View Article and Find Full Text PDF

Cointegrate/hybrid plasmids combine the genetic elements of two or more plasmids and generally carry abundant antimicrobial resistance determinants. Hence, the spread of cointegrate plasmids will accelerate the transmission of AMR genes. To evaluate the transmission risk caused by cointegrate plasmids, we investigated the structural diversity, fitness cost, and stability of a cointegrate plasmid in YZ6 and EC600.

View Article and Find Full Text PDF

EGFR inhibitors have revolutionized the treatment of advanced non-small-cell lung cancer (NSCLC). Mefatinib is a novel, bioavailable, second-generation, irreversible pan-EGFR inhibitor. This phase Ib/II open-label, single-arm, multi-center study investigated the efficacy, safety, biomarker, and resistance mechanisms of mefatinib in the first-line treatment of patients with advanced EGFR-mutant NSCLC.

View Article and Find Full Text PDF
Article Synopsis
  • * The study revealed that GA effectively hinders SARS-CoV-2 infection by blocking the virus's ability to attach to host cells via its spike (S) protein.
  • * Analysis indicated that GA binds to specific sites on the S protein, preventing it from interacting with ACE2, the receptor needed for viral entry into cells.
View Article and Find Full Text PDF
Article Synopsis
  • Adenoviral DNA is frequently found in tonsil specimens from children who undergo adenotonsillectomy, suggesting the virus remains in a latent state.
  • In a study of 81 patients, 85.2% of the tonsil samples tested positive for human adenovirus (HAdV), revealing a link between specific tonsil microbiota profiles and the presence of the virus.
  • The research indicates that certain bacteria and short-chain fatty acids present in the tonsils may contribute to the reactivation of HAdV, potentially leading to respiratory infections, particularly in children and organ transplant recipients.
View Article and Find Full Text PDF

Background: The objective of this study was to assess human adenovirus (HAdV) infection in juvenile polyps (JPs) and to preliminarily establish a correlation to vitamin D receptor (VDR) expression.

Methods: The study includes 76 patients of 5.2 ± 2.

View Article and Find Full Text PDF

Progressive acute respiratory distress syndrome (ARDS) is the most lethal cause in patients with severe COVID-19 pneumonia due to uncontrolled inflammatory reaction, for which we found that early intervention of combined treatment with methylprednisolone and human immunoglobulin is a highly effective therapy to improve the prognosis of COVID-19-induced pneumonia patients. . Herein, we have demonstrated the clinical manifestations, laboratory, and radiological characteristics of patients with severe Coronavirus Disease-2019 (COVID-19) pneumonia, as well as measures to ensure early diagnosis and intervention for improving clinical outcomes of COVID-19 patients.

View Article and Find Full Text PDF

LINC01089, a newly discovered long non-coding RNA (lncRNA), has been reported to inhibit the progression of various types of cancers. This study aimed to characterize LINC01089 in the pathogenesis of lung adenocarcinoma (LUAD). LINC01089 expression in LUAD tissues or/and cells and its association with the overall survival of LUAD patients was analyzed in The Cancer Genome Atlas (TCGA)-LUAD database, by qRT-PCR or by Kaplan-Meier's curve.

View Article and Find Full Text PDF

The IS6 family of bacterial and archaeal insertion sequences, first identified in the early 1980s, has proved to be instrumental in the rearrangement and spread of multiple antibiotic resistance. Two IS, IS26 (found in many enterobacterial clinical isolates as components of both chromosome and plasmids) and IS257 (identified in the plasmids and chromosomes of gram-positive bacteria), have received particular attention for their clinical impact. Although few biochemical data are available concerning the transposition mechanism of these elements, genetic studies have provided some interesting observations suggesting that members of the family might transpose using an unexpected mechanism.

View Article and Find Full Text PDF